SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-004631
Filing Date
2014-10-29
Accepted
2014-10-29 16:05:51
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cemp-10q_20140930.htm 10-Q 1255443
2 EX-31.1 cemp-ex311_201409309.htm EX-31.1 14509
3 EX-31.2 cemp-ex312_2014093010.htm EX-31.2 14458
4 EX-32.1 cemp-ex321_2014093011.htm EX-32.1 5720
5 EX-32.2 cemp-ex322_2014093012.htm EX-32.2 5645
  Complete submission text file 0001564590-14-004631.txt   7088679

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cemp-20140930.xml EX-101.INS 1213056
7 XBRL TAXONOMY EXTENSION SCHEMA cemp-20140930.xsd EX-101.SCH 42524
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cemp-20140930_cal.xml EX-101.CAL 34335
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cemp-20140930_def.xml EX-101.DEF 119242
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemp-20140930_lab.xml EX-101.LAB 320023
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemp-20140930_pre.xml EX-101.PRE 237036
Mailing Address 6320 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149 919-313-6617
CEMPRA, INC. (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35405 | Film No.: 141180218
SIC: 2834 Pharmaceutical Preparations